lefamulin
Antiinfectives for systemic use (J01)Antiinfectives for systemic use (J01) compound in Nabriva Therapeutics's portfolio.
pharma · Community Acquired Pneumonia
Nabriva Therapeutics
Nabriva Therapeutics Ireland DAC
Nabriva Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
IE HQ
2006 Founded
25 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- IE
- Founded
- 2006
- Employees
- 25
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Nabriva Therapeutics pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Nabriva Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.